Structure Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	169.51	129.79	26.09	105.31	16.35
Short-Term Investments	714.01	337.53	64.75	2	21.09
Cash & Short-Term Investments	883.52	467.32	90.84	107.31	37.45
Cash Growth	89.06%	414.44%	-15.35%	186.57%	-
Prepaid Expenses	7.69	6.29	2.25	1.94	0.97
Total Current Assets	891.21	473.61	93.09	109.25	38.42
Property, Plant & Equipment	7.01	8.36	1.29	1.79	0.28
Long-Term Deferred Charges	-	-	3.4	0.1	-
Other Long-Term Assets	5.11	0.05	0.06	0.01	0.01
Total Assets	903.33	482.02	97.85	111.16	38.7
Accounts Payable	8.02	4.74	6.01	3.48	1.53
Accrued Expenses	26.3	18.56	6.57	4.59	1.23
Current Portion of Leases	1.7	1.44	0.26	0.35	0.15
Current Income Taxes Payable	-	-	0.17	0.23	0.14
Total Current Liabilities	36.02	24.74	13.01	8.66	3.04
Long-Term Leases	2.16	4.01	-	0.27	0.13
Other Long-Term Liabilities	0.3	0.3	-	-	-
Total Liabilities	38.49	29.05	13.01	8.93	3.17
Common Stock	0.02	0.01	0	0	0
Additional Paid-In Capital	1,193	659	1.92	-	0.48
Retained Earnings	-329.1	-206.57	-116.95	-64.74	-22.95
Comprehensive Income & Other	0.91	0.52	-0.11	-	-0
Total Common Equity	864.84	452.97	-115.14	-64.74	-22.47
Shareholders' Equity	864.84	452.97	84.84	102.23	35.53
Total Liabilities & Equity	903.33	482.02	97.85	111.16	38.7
Total Debt	3.86	5.45	0.26	0.62	0.28
Net Cash (Debt)	879.66	461.87	90.58	106.69	37.17
Net Cash Growth	90.45%	409.90%	-15.10%	187.06%	-
Net Cash Per Share	16.71	12.57	28.35	39.31	17.81
Filing Date Shares Outstanding	57.34	46.6	38.24	3.63	3.62
Total Common Shares Outstanding	57.29	46.41	3.51	3.63	3.62
Working Capital	855.19	448.87	80.08	100.59	35.38
Book Value Per Share	15.10	9.76	-32.81	-17.83	-6.20
Tangible Book Value	864.84	452.97	-115.14	-64.74	-22.47
Tangible Book Value Per Share	15.10	9.76	-32.81	-17.83	-6.20
Machinery	3.75	2.51	1.27	1.15	0.02
Leasehold Improvements	1.36	1.36	0.11	0.11	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q